Company: VCYT
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001384101-25-000130
Chunk: 38

Company: VERACYTE, INC.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part I, Item 1
Chunk 38
---
 activities across the consolidated entity in order to operate. No individual besides the chief operating decision maker has been tasked with reviewing discreet operating results of the business activities, nor is there any intent to bifurcate the overall business review process to produce discreet operating results specific to any of the Company's business activities. The measure of segment assets is reported on the consolidated balance sheet as total consolidated assets. Consolidated revenue does not include any inter-segment sales or transfers.

19

Information about reported segment revenue, measures of segment profit or loss, significant segment expenses and reconciliation to income from operations was as follows (in thousands):Three Months Ended September 30,Nine Months Ended September 30,2025202420252024Revenue:Testing revenue$127,756 $109,536 $357,328 $306,809 Product revenue3,301 3,188 10,479 10,631 Biopharmaceutical and other revenue815 3,136 8,702 9,692 Total revenue131,872 115,860 376,509 327,132 Cost of revenue:Cost of testing revenue:Laboratory supplies and reagents expense14,766 13,887 43,134 39,131 Sample collection expense3,078 3,663 9,398 9,884 Compensation expense6,273 5,743 17,906 16,097 Other cost of testing revenue (1)6,456 2,797 14,017 9,122 Allocation of facilities and IT expenses3,204 2,939 9,989 8,694 Total cost of testing revenue33,777 29,029 94,444 82,928 Cost of product revenue:Product costs1,050 545 1,864 2,436 License fees and royalties257 270 888 1,021 Other cost of product revenue (2)1,672 750 2,980 2,372 Allocation of facilities and IT expenses36 227 454 481 Total cost of product revenue3,015 1,792 6,186 6,310 Cost of biopharmaceutical and other revenue:Compensation expense426 1,424 3,318 4,958 Other cost of biopharmaceutical and other revenue (3)612 1,024 3,118 3,244 Allocation of facilities and IT expenses